Nebula Research & Development LLC Novo Cure LTD Transaction History
Nebula Research & Development LLC
- $618 Billion
- Q2 2024
A detailed history of Nebula Research & Development LLC transactions in Novo Cure LTD stock. As of the latest transaction made, Nebula Research & Development LLC holds 21,042 shares of NVCR stock, worth $374,968. This represents 0.06% of its overall portfolio holdings.
Number of Shares
21,042Holding current value
$374,968% of portfolio
0.06%Shares
1 transactions
Others Institutions Holding NVCR
# of Institutions
268Shares Held
79.4MCall Options Held
751KPut Options Held
293K-
Black Rock Inc. New York, NY12.1MShares$216 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA11.7MShares$208 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.1MShares$198 Million0.0% of portfolio
-
Nordwand Advisors, LLC Radnor, PA3.03MShares$54 Million12.67% of portfolio
-
State Street Corp Boston, MA3.01MShares$53.6 Million0.0% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $1.87B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...